Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

[Should we treat prostate cancer?].

Desgrandchamps F, Hennequin C.

Rev Prat. 2013 Apr;63(4):465-8. French. No abstract available.

PMID:
23682466
3.

To treat or not to treat: is the way forward clearer in low-risk prostate cancer?

Gnanapragasam VJ.

BJU Int. 2013 Aug;112(3):285-7. doi: 10.1111/j.1464-410X.2012.11723.x. Epub 2013 Mar 7. No abstract available.

4.

[Watchful waiting in incidental adenocarcinoma of the prostate].

Morán Pascual E, Dicapua Sacoto C, Trassierra Villa M, Pontones Moreno JL, Ruiz Cerdá JL, Jiménez Cruz JF.

Actas Urol Esp. 2010 Nov;34(10):854-9. Spanish.

PMID:
21159280
5.

Watchful waiting for prostate cancer: a review article.

Chodak GW, Warren KS.

Prostate Cancer Prostatic Dis. 2006;9(1):25-9. Review.

PMID:
16402090
6.

Active surveillance for prostate cancer: barriers to widespread adoption.

Sandhu GS, Andriole GL.

Eur Urol. 2012 Dec;62(6):984-5. doi: 10.1016/j.eururo.2012.06.047. Epub 2012 Jun 30. No abstract available.

PMID:
22770662
7.

More US men with low risk prostate cancer opt for watchful waiting.

McCarthy M.

BMJ. 2015 Jul 10;351:h3777. doi: 10.1136/bmj.h3777. No abstract available.

PMID:
26163150
8.

Prostate cancer: who should be treated?

[No authors listed]

Am Fam Physician. 2011 Aug 15;84(4):424. No abstract available.

9.

Cost effectiveness of treatment options for early prostate cancer: can we put the puzzle pieces together?

Xie F.

Eur Urol. 2013 Feb;63(2):411-2. doi: 10.1016/j.eururo.2012.11.025. Epub 2012 Nov 16. No abstract available.

PMID:
23177080
10.

Active surveillance monitoring more stringent in updated NCCN Guidelines for prostate cancer.

[No authors listed]

J Natl Compr Canc Netw. 2011 May;9(5):xxxvii-xlii. No abstract available.

PMID:
21739727
11.

Critical review: is watchful waiting a viable management option for older men with prostate cancer?

Bailey DE Jr, Wallace M.

Am J Mens Health. 2007 Mar;1(1):18-28. doi: 10.1177/1557988306294161. Review.

PMID:
19482780
12.

Observation versus initial treatment for prostate cancer.

Pinsky P.

Ann Intern Med. 2013 Oct 15;159(8):574. doi: 10.7326/0003-4819-159-8-201310150-00015. No abstract available.

PMID:
24126652
13.

Expectant management of localized prostate cancer--who, what, when, where and how?

Ehdaie B.

J Urol. 2012 Sep;188(3):696-7. doi: 10.1016/j.juro.2012.06.049. Epub 2012 Jul 19. No abstract available.

PMID:
22818346
14.

Does delaying prostate cancer treatment miss the window of curability?

Loeb S.

Eur Urol. 2013 Aug;64(2):216-7; discussion 217-8. doi: 10.1016/j.eururo.2013.03.051. Epub 2013 Apr 8. No abstract available.

PMID:
23619388
15.

Treater to target: a urologist's personal experience with prostate cancer.

Schellhammer PF.

J Natl Cancer Inst Monogr. 2012 Dec;2012(45):143-5. doi: 10.1093/jncimonographs/lgs027. No abstract available.

16.

Is it time to miss the target for prostate cancer?

Hellawell GO, Bhardwa J.

BJU Int. 2012 Feb;109(4):492-3. doi: 10.1111/j.1464-410X.2011.10857.x. No abstract available.

17.

You're kidding...I have cancer? A patient's perspective on coping with prostate cancer and why active surveillance was not chosen.

Lipton DA.

J Natl Cancer Inst Monogr. 2012 Dec;2012(45):140-2. doi: 10.1093/jncimonographs/lgs034. No abstract available.

18.

Words of wisdom. Re: Medium-term outcomes of active surveillance for localized prostate cancer.

Mir MC, Stephenson AJ.

Eur Urol. 2013 Dec;64(6):1013-4. doi: 10.1016/j.eururo.2013.09.030. No abstract available.

PMID:
24209447
19.

Treating prostate cancer.

Parker C.

BMJ. 2012 Aug 1;345:e5122. doi: 10.1136/bmj.e5122. No abstract available.

PMID:
22859773
20.

Prostate cancer diagnosis: surgery or not?

[No authors listed]

Aust Nurs J. 2012 Nov;20(5):49. No abstract available.

PMID:
23316506

Supplemental Content

Support Center